Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25


Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late Proteins.

Niu TK, Princiotta MF, Sei JJ, Norbury CC.

Immunohorizons. 2019 Dec 2;3(12):559-572. doi: 10.4049/immunohorizons.1900074.


The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine (CYD-TDV): A Phase II, Randomized, Open-label, Single Center Trial in Adults Aged 18 to 45 years in the United States.

Glass A, Polhemus M, Wang D, Jarman RG, Thomas SJ, Friberg H, Currier JR, Bonaparte M, De La Barra R, Princiotta MF, Abbott M, Cuzzo B, Machabert T, Sridhar S, Endy TP.

J Infect Dis. 2019 Nov 22. pii: jiz592. doi: 10.1093/infdis/jiz592. [Epub ahead of print]


Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.

Villarreal DO, L'Huillier A, Armington S, Mottershead C, Filippova EV, Coder BD, Petit RG, Princiotta MF.

Cancer Res. 2018 Sep 15;78(18):5340-5348. doi: 10.1158/0008-5472.CAN-18-1119. Epub 2018 Jul 19.


Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice.

Samuelson EM, Laird RM, Papillion AM, Tatum AH, Princiotta MF, Hayes SM.

PLoS One. 2014 Mar 17;9(3):e92054. doi: 10.1371/journal.pone.0092054. eCollection 2014.


γδ T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a Listeria model of infection independently of CD28 costimulation.

Laird RM, Wolf BJ, Princiotta MF, Hayes SM.

PLoS One. 2013 May 9;8(5):e63178. doi: 10.1371/journal.pone.0063178. Print 2013.


Connexin43 is dispensable for phagocytosis.

Glass AM, Wolf BJ, Schneider KM, Princiotta MF, Taffet SM.

J Immunol. 2013 May 1;190(9):4830-5. doi: 10.4049/jimmunol.1202884. Epub 2013 Apr 3.


Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathway.

Wolf BJ, Princiotta MF.

J Immunol. 2013 Mar 15;190(6):2501-9. doi: 10.4049/jimmunol.1201660. Epub 2013 Feb 8.


All roads lead to "ome": defining the DRiPome.

Yewdell JW, Princiotta MF.

Blood. 2012 Jun 28;119(26):6179-80. doi: 10.1182/blood-2012-04-420810. No abstract available.


A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Hunzeker JT, Elftman MD, Mellinger JC, Princiotta MF, Bonneau RH, Truckenmiller ME, Norbury CC.

J Immunol. 2011 Jan 1;186(1):183-94. doi: 10.4049/jimmunol.1001737. Epub 2010 Nov 22.


Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies.

Wolf BJ, Princiotta MF.

Mol Immunol. 2011 Jan;48(4):463-71. doi: 10.1016/j.molimm.2010.10.002. Epub 2010 Nov 10.


Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.

Lev A, Princiotta MF, Zanker D, Takeda K, Gibbs JS, Kumagai C, Waffarn E, Dolan BP, Burgevin A, Van Endert P, Chen W, Bennink JR, Yewdell JW.

Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6964-9. doi: 10.1073/pnas.0910997107. Epub 2010 Mar 29.


The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation.

Lev A, Takeda K, Zanker D, Maynard JC, Dimberu P, Waffarn E, Gibbs J, Netzer N, Princiotta MF, Neckers L, Picard D, Nicchitta CV, Chen W, Reiter Y, Bennink JR, Yewdell JW.

Immunity. 2008 Jun;28(6):787-98. doi: 10.1016/j.immuni.2008.04.015.


Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control.

Qian SB, Princiotta MF, Bennink JR, Yewdell JW.

J Biol Chem. 2006 Jan 6;281(1):392-400. Epub 2005 Nov 1.


Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation.

Truckenmiller ME, Princiotta MF, Norbury CC, Bonneau RH.

J Neuroimmunol. 2005 Mar;160(1-2):48-60. Epub 2004 Dec 23.


CD8+ T cell cross-priming via transfer of proteasome substrates.

Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P, Gibbs J, Bennink JR, Yewdell JW.

Science. 2004 May 28;304(5675):1318-21.


Proteasomes get by with lots of help from their friends.

Yewdell JW, Princiotta MF.

Immunity. 2004 Apr;20(4):362-3. Review.


Phagosomes are competent organelles for antigen cross-presentation.

Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, Laplante A, Princiotta MF, Thibault P, Sacks D, Desjardins M.

Nature. 2003 Sep 25;425(6956):402-6.


Quantitating protein synthesis, degradation, and endogenous antigen processing.

Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, Buttgereit F, Bennink JR, Yewdell JW.

Immunity. 2003 Mar;18(3):343-54.


Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.

Norbury CC, Princiotta MF, Bacik I, Brutkiewicz RR, Wood P, Elliott T, Bennink JR, Yewdell JW.

J Immunol. 2001 Apr 1;166(7):4355-62.


Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival.

Princiotta MF, Schubert U, Chen W, Bennink JR, Myung J, Crews CM, Yewdell JW.

Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):513-8. Epub 2001 Jan 9.


Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.

Schubert U, Ott DE, Chertova EN, Welker R, Tessmer U, Princiotta MF, Bennink JR, Krausslich HG, Yewdell JW.

Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13057-62.


A physiological ligand of positive selection is recognized as a weak agonist.

Berg RE, Irion S, Kattman S, Princiotta MF, Staerz UD.

J Immunol. 2000 Oct 15;165(8):4209-16.


Positive selection of an H2-M3 restricted T cell receptor.

Berg RE, Princiotta MF, Irion S, Moticka JA, Dahl KR, Staerz UD.

Immunity. 1999 Jul;11(1):33-43.


Intracellular localization of proteasomal degradation of a viral antigen.

Antón LC, Schubert U, Bacík I, Princiotta MF, Wearsch PA, Gibbs J, Day PM, Realini C, Rechsteiner MC, Bennink JR, Yewdell JW.

J Cell Biol. 1999 Jul 12;146(1):113-24.


H2-M3 restricted presentation of a Listeria-derived leader peptide.

Princiotta MF, Lenz LL, Bevan MJ, Staerz UD.

J Exp Med. 1998 May 18;187(10):1711-9.

Supplemental Content

Loading ...
Support Center